Receptor activator of nuclear factor κb ligand is a novel inducer of tissue factor in macrophages

Circulation Research

Volumn 107, Issue 7, 2010, Pages 871-876

  Kim, Jihye ^a   Min, Jeong Ki ^b   Park, Jeong Ae ^a   Doh, Hyun Ju ^d   Choi, Yeon Sook ^a   Rho, Jaerang ^c   Kim, Young Myeong ^e   Kwon, Young Guen ^a  

^a Yonsei University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Chungnam National University   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e Kangwon National University   (South Korea)

Author keywords

atherosclerosis; receptor activator of nuclear factor B ligand; thrombosis; tissue factor

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PROCOAGULANT; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; THROMBOPLASTIN; TRANSCRIPTION FACTOR AP 1; DNA ENZYME ED5; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; SINGLE STRANDED DNA; TNFSF11 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; CARDIOVASCULAR RISK; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; ATHEROSCLEROSIS; CELL LINE; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; RISK FACTOR; THROMBOSIS;

ANIMALS; ATHEROSCLEROSIS; CELL LINE; DNA, SINGLE-STRANDED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACROPHAGES, PERITONEAL; MAP KINASE SIGNALING SYSTEM; MICE; PHOSPHORYLATION; RANK LIGAND; RISK FACTORS; RNA, MESSENGER; RNA, SMALL INTERFERING; THROMBOPLASTIN; THROMBOSIS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 77958010783     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.110.221168     Document Type: Article

References (17)

1. Sanz J, Fayad ZA. Imaging of atherosclerotic cardiovascular disease. Nature. 2008;451:953-957.
2. Lusis AJ. Atherosclerosis Nature. 2000;407:233-241.
3. Steffel J, Lüscher TF, Tanner FC. Tissue factor in cardiovascular diseases: Molecular mechanisms and clinical implications. Circulation. 2006;113:722-731.
4. Mackman N. Triggers, targets and treatments for thrombosis. Nature. 2008;451:914-918.
5. Collin-Osdoby P. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res. 2004;95: 1046-1057.
6. Ali AS, Lax AS, Liljeström M, Paakkari I, Ashammakhi N, Kovanen PT, Konttinen YT. Mast cells in atherosclerosis as a source of the cytokine RANKL. Clin Chem Lab Med. 2006;44:672-674.
7. Sandberg WJ, Yndestad A, Øie E, Smith C, Ueland T, Ovchinnikova O, Robertson AKL, Müller F, Semb AG, Scholz H, Andreassen AK, Gullestad L, Damås JK, Frøland SS, Hansson GK, Halvorsen B, Aukrust P. Enhanced T-cell expression of RANK ligand in acute coronary syndrome: Possible role in plaque destabilization. Arterioscler Thromb Vasc Biol. 2006;26:857-863.
8. Panizo S, Cardus A, Encinas M, Parisi E, Valcheva P, López-Ongil S, Coll B, Fernandez E, Valdivielso JM. RANKL increases vascular smooth muscle cell calcification through a rank-bmp4-dependent pathway. Circ Res. 2009;104:1041-1048.
9. Min JK, Kim YM, Kim SW, Kwon MC, Kong YY, Hwang IK, Won MH, Rho J, Kwon YG. TNF-related activation-induced cytokine enhances leukocyte adhesiveness: Induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NFkB activation in endothelial cells. J Immunol. 2005;175:531-540.
10. Min JK, Cho YL, Choi JH, Kim Y, Jeong HK, Young SY, Rho J, Mochizuki N, Kim YM, Goo TO, Kwon YG. Receptor activator of nuclear factor (NF)-kB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice. Blood. 2007;109:1495-1502.
11. Kiechl S, Schett G, Schwaiger J, Seppi K, Eder P, Egger G, Santer P, Mayr A, Xu Q, Willeit J. Soluble receptor activator of nuclear factor-kB ligand and risk for cardiovascular disease. Circulation. 2007;116: 385-391.
12. Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nature Medicine. 2003;9:458-462.
13. Censarek P, Bobbe A, Grandoch M, Schrör K, Weber AA. Alternatively spliced human tissue (asHTF) is not pro-coagulant. Thromb Haemost. 2007;97:11-14.
14. Alexander MY. Editorial: RANKL links arterial calcification with oste-olysis. Circ Res. 2009;104:1032-1034.
15. Jiang XC, Liu J, Huan C, Chakraborty M, Zhang H, Lu D, Kuo MS, Cao G. Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice. Circ Res. 2009;105:295-303.
16. Harja E, Bucciarelli LG, Lu Y, Stern DM, Zou YS, Schmidt AM, Yan SF. Early growth response-1 promotes atherogenesis: mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation. Circ Res. 2004;94:333-339.
17. Combs MD, Yutzey KE. VEGF and RANKL regulation of NFATc1 in heart valve development. Circ Res. 2009;105:565-574.